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University of the Witwatersrand, South Africa 
Of 259 patients admitted to an intensive care unit with severe acute community-acquired pneumonia, 173 had 
primary infections and 86 had secondary infections. The commonest organism isolated in each group was 
Streptococcus pneumoniae (51.3 and 36.6% of known isolates in each group respectively). Klebsiella 
pneumoniae was the next most common isolate (31.9 and 29.3% respectively). A variety of other Gram- 
negative organisms and Staphylococcus aureus accounted for most of the remaining pathogens. 
Based on retrospective analysis of data, there appeared to be no difference in the alcohol consumption of 
patients with infection due to S. pneumoniae and K. pneumoniae. The overall mortality rate for the primary 
infections was 47.4%, with 684% of these infections due to K. pneumoniae and 33.9% due to the 
pneumococcus (P<O.O02). Among the secondary infections, the overall mortality rate was 40.8% (not 
significantly different to that of primary infections) with 455% due to K. pneumoniae and 23.1% due to the 
pneumococcus (not significantly different on statistical analysis, probably due to low patient numbers). Our 
investigation confirms that severe community-acquired pneumonia due to X pneumoniae is extremely 
common, even in patients without obvious risk factors for Gram-negative colonization. This organism is 
contributing to the high mortality rate seen in our intensive care unit among patients with pneumonia, and our 
empiric therapy for such cases routinely includes a combination of agents active against this organism (e.g. a 
cephalosporin and an aminoglycoside). 
Introduction 
Community-acquired pneumonia continues to be 
associated with significant morbidity and mortality in 
patients world-wide (l-3). Not all factors associated 
with this ongoing mortality are completely under- 
stood, but it is recognized that critically-ill patients 
(4,5), and cases with certain initial clinical and 
laboratory features of illness, noted at the time of 
presentation to hospital, have a worse prognosis 
(4-8). There is indirect evidence, based on experimen- 
tal and human studies, that delayed or incorrect 
empiric antibiotic therapy may be associated with a 
poorer prognosis in patients with pneumonia (6,9). In 
addition, two recent publications have suggested that 
the initial antibiotic therapy used in patients with 
severe community-acquired pneumonia may have an 
impact on patient survival (7,8). 
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Initial antibiotic therapy in pneumonia is, of 
necessity, empiric and is based on a consideration of 
several factors, including an appreciation of the com- 
mon causes of such infections in the different areas 
(1612). Importantly, and influencing the choice of 
initial therapy, is the ongoing debate as to the usual 
bacterial causes of pneumonia, particularly among 
cases of severe community-acquired pneumonia 
(SCAP), and with special reference to the prevalence 
of Gram-negative organisms (other than Huemo- 
philus influenzae). Thus, while some studies have 
shown Gram-negative organisms to be relatively 
more common causes of SCAP (5,7,13-15), others 
have not confirmed these findings (6,9,16,17). It has 
been suggested that those studies showing a high 
prevalence of Gram-negative organisms may be due 
to a high intake of alcohol in patient populations 
(17). Others have suggested that the prevalence of 
Gram-negative organisms in any particular study 
may relate to the invasiveness of the diagnostic 
approach; those studies using more aggressive 
approaches to diagnosis uncovering a larger group of 
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Gram-negative infections (18). From our own unit, 
we have published data showing Gram-negative 
organisms, in particular K. pneumoniae, to be 
important causes of SCAP (5,19). 
The aim of the present investigation was to docu- 
ment the causes of SCAP among patients admitted 
to our intensive care unit (ICU) over an 1 I-yr period. 
In particular, we wished to determine (a) whether 
K. pneumoniae remained an important cause of 
SCAP when extending our initial observations over a 
much longer period of time, (b) to document whether 
such infections occurred as frequently when only 
patients with pure primary community-acquired 
infections (community-acquired cases without any 
underlying disorder whatsoever) were included and 
(c) to investigate the possible association of an 
increased prevalence of such infections with regular 
alcohol consumption. 
Patients and Methods 
This was a retrospective view of the records of 
all patients with an admission diagnosis of acute 
SCAP treated in the Hillbrow Hospital ICU in 
Johannesburg, between January 1982 and December 
1992. Approval to conduct the study was obtained 
from the Committee for Research on Human 
Subjects of the University of the Witwatersrand. 
Acute community-acquired pneumonia was 
defined as an acute lower respiratory tract infection 
associated with clinical and radiological evidence of 
pulmonary consolidation. All cases entered into the 
study had been admitted to the Hospital from the 
community, and were taken into the ICU within 24 h 
of admission to the Hospital. In order to study cases 
without apparent specific predisposing factors to 
Gram-negative infections, the patient population was 
divided into primary infections (defined as those 
cases with no apparent predisposing factors to illness 
whatsoever, aside perhaps from a history of regular 
ingestion of alcohol), and secondary infections 
(defined as those cases with known underlying disor- 
ders including diabetes mellitus, asthma and chronic 
obstructive airways disease, immunosuppression, 
malignancies, and evidence from clinical or labora- 
tory investigations of other chronic disorders) as 
described previously (20). Patients were admitted to 
the ICU usually for mechanical ventilation, or 
because they were critically-ill and expected to need 
intensive medical and nursing care, multiple changes 
in therapy, and possible mechanical ventilation. 
The data recorded included age and gender, his- 
tory of alcohol ingestion, results of microbiological 
investigation and outcome. In cases with primary 
infections we also recorded the presence or absence of 
those features noted in previous studies to be associ- 
ated with SCAP (i.e. the need for ICU admission), as 
well as the treatment received in ICU, including 
mechanical ventilation, inotropic support of the 
blood pressure and dialysis. In this group of patients, 
once APACHE II scoring became routinely used in 
the unit, these results were documented as well (21). 
In the secondary group of patients we recorded, 
additionally, the reasons for the characterization of 
cases within this group. 
The microbiological data were based primarily on 
the results of blood cultures and/or on Gram stain 
and/or culture of expectorated sputum or endo- 
tracheal secretions, taken from patients within 24 h 
of admission to hospital. Serological testing for 
Legionella and Mycoplasma infections and for the 
various respiratory viruses had been performed only 
in some cases, usually based on clinical suspicion of 
an ‘atypical’ infection. 
Statistical analysis, using the Fisher’s exact (2-tail) 
test, was undertaken to compare the mortality of 
patients with primary and with secondary infections, 
to compare mortality in patients with infections due 
to the pneumococcus and due to K. pneumoniae, and 
to compare alcohol consumption in patients with 
these two infections. 
ReSUlts 
A total of 280 patients with acute community- 
acquired pneumonia were admitted to our ICU over 
the 11-yr period. In 21 cases, Mycobacterium 
tuberculosis was isolated from sputum (with or with- 
out the presence of co-existent bacteria in blood 
and/or sputum) and these cases were excluded from 
further analysis. Thus, there were 173 primary, and 
86 secondary infections. 
Of the patients with primary infections, 134 were 
males and 39 females. The mean age was 43.6 years 
(range 14-74 years), and the mean ( f SD) Apache II 
score was 15.8 ( f 8.9). The microbiological data of 
these patients are shown in Table 1. A positive 
diagnosis was made in 119 cases (68.8%), no organ- 
isms being isolated in the remainder. The commonest 
organism isolated was S. pneumoniae, accounting for 
51.3% of the isolates, and the second commonest 
organism isolated was K. pneumoniae, accounting for 
31.9% of the isolates. A variety of other Gram- 
negative organisms (9.2%) and Staphylococcus 
aureus (3.4%) accounted for most of the remaining 
isolates. In 26 patients, serological testing had been 
undertaken and demonstrated two infections with 
Mycoplasma pneumoniae and one with Legionella 
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Table I The aetiology of primary acute severe community-acquired pneumonia in 173 patients 
Micro-organisms 
Total no. 
of isolates 
% of 
positive cultures 
Blood and 
sputum Blood Sputum Serology 
Streptococcus pneumoniae 61* 51.3 
Klebsiella pneumoniae 38 31.9 
Other Gram negative 8§ 6.1 
Staphylococcus aureus 411 3.4 
Mixed Gram negative 3 2.5 
Mycoplasma pneumoniae 2 1.7 
Legionella pneumophila 1 0.8 
Virafl 2 1.7 
11 38tS lot 
2 27 9 
1 3 4 
- 3 
1 2 
- 2 
- 1 
- 2 
*, site of isolation in two cases not documented. 
t, the isolate in each case from cerebrospinal fluid as well. 
$, one bactec positive, culture negative, blood positive countercurrent immunoelectrophoresis. 
Q, Eseherichia coli (2 cases), Haemophilus i@uenzae (2) Serratia marcescens (2) Proteus mirabilis (1) and Acinetobacter 
anitratus (1). 
11, site of isolation in one case not documented. 
Warainfluenza virus infection diagnosed on serology and influenza virus infection diagnosed on lung biopsy and serology. 
Table 2 The frequency of admission features found in patients with primary community- 
acquired pneumonia associated with severe infection* 
Feature 
Number present/total number of cases in 
whom feature was documented (0/o) 
Respiratory rate >30 breaths min ’ 
Confusion 
Absent chest pain 
Diastolic blood pressure ~60 mmHg 
P,O, ~8 kPa 
Leucocytes <4 or >20 X lo9 1~ ’ 
Lymphocytes < 1 x lo9 1~ ’ 
Sodium < 130 mmol 1 - ’ 
Urea >7 mm01 1 - ’ 
Albumin ~30 g I- ’ 
Abnormal liver functiont 
94/145 (648) 
42/76(553) 
3/41 (7.3) 
22/100 (22) 
40/100 (40) 
85/170 (SO) 
2/81 (2.5) 
44/l 69 (26) 
108/170 (63.2) 
94/132 (71.2) 
77021 (63.6) 
*Modified after the British Thoracic Society publication in Respiratory Medicine (17), 
reproduced with permission. 
tAt least one value twice the upper limit of normal. 
pneumophila. Forty-one patients, according to the 
history recorded, consumed alcoholic beverages on a 
regular basis. There was no significant difference in 
the alcohol consumption of patients with pneumo- 
The frequency of features associated with the 
need for ICU admission in patients with pneumonia 
coccal and K. pneumoniae infections (72.7 vs. 654% 
[British Thoracic Society (17)] noted in our patients, 
are demonstrated in Table 2. Confusion, tachypnoea, 
respectively). 
raised urea and liver enzymes, low albumin, extremes 
of leucocyte count, and hypoxia were among the 
most important features. Treatment of these patients 
included mechanical ventilation in 85.9%, use of 
inotropic agents in 69.2% and dialysis in 22.2%. 
The overall mortality rate was 47.40/o, this being 
68.4% in patients with documented K. pneumoniae 
infection and 33.9% in documented pneumococcal 
Of the 86 patients with secondary infections, 66 
infections (PcO.002). The mortality rate in patients in 
were males and 20 females, with a mean age of 45.0 
years (range 2&75 years). The reasons for the classi- 
whom no microbiological diagnosis was made was 
fication of these infections as secondary are shown in 
Table 3. The most common reasons for inclusion 
46.3%. 
were the presence of underlying lung disorders, and 
diabetes mellitus. The microbiological results are 
shown in Table 4; in 40 cases a specific diagnosis was 
made (47.7%). The common organisms documented 
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Table 3 Features present in 86 patients classified as having 
secondary acute severe community-acquired pneumonia 
Feature 
Number of 
patients 
Respiratory diseases 
Old fibrocavitatory TB 
Chronic obstructive 
airways disease/corpulmonale 
Asthma on systemic corticosteroids 
Bronchiectasis 
Pneumothorax (recurrent) 
Carcinoma of the lung 
Trachea-oesophageal fistula 
Pneumoconiosis 
Diabetes mellitus 
Presentation in coma 
General disorders 
Severe malnutrition 
Neurological 
Connective tissue disorder 
HIV positive 
Poisoning 
Malignancy (4) 
Chronic lymphatic leukaemia 
Myeloma 
Renal disease 
Chronic renal failure 
Other 
Cardiovascular disease 
Congestive cardiac failure/ 
cardiomyopathy 
49 
20 
16 
4 
3 
19 
15 
5 
5 
3 
2 
1 
1 
2 
2 
2 
2 
3 
in this group were the pneumococcus (36.6%), K. 
pneumoniae (29.3%), other Gram-negative organisms 
(22.0%) and S. aureus (9Wo). In 10 cases, serological 
testing for Legionella, Mycoplasma or viral infections 
had been undertaken and no cases identified. No 
microbiological diagnosis was made in 52.3% of 
patients. 
The overall mortality for this group was 40.8%, 
which was not significantly different from that found 
in the group of patients with primary infections. The 
mortality was 45.5% for the K. pneumoniae group 
and 23.1% for the pneumococcal group of infections 
(not significantly different). The mortality rate in 
patients with negative microbiological testing was 
42.1%. 
Discussion 
This study documents the aetiology of acute SCAP 
among a large number of patients admitted to the 
ICU of an urban general hospital in Johannesburg, 
South Africa. While the pneumococcus was the 
commonest isolate, the study confirms that Gram- 
negative isolates, and in particular K. pneumoniae, 
account for a significant proportion of the remaining 
cases (Tables 1 and 4). In our study we recorded, but 
subsequently excluded from further analysis, patients 
with infection due to M tuberculosis (of which there 
were 21 cases). The reason for drawing attention to 
these cases is that this study and several previous 
investigations, in both ICU and non-ICU settings 
(13,15,22,23), have shown that infection with this 
organism may commonly present as an apparent 
acute community-acquired pneumonia in countries 
with a high prevalence of tuberculosis. 
A number of studies in recent years have investi- 
gated the aetiology of community-acquired pneumo- 
nia in different countries. Previous studies in 
critically-ill cases, particularly from Spain (7,14,15) 
have suggested that Gram-negative infections are 
common. This has also been true in studies among 
critically-ill cases in South Africa (5,13). However, 
this is in contradiction to several studies from the 
U.K. in which Gram-negative organisms have not 
featured as important pathogens even among 
severely-ill patients (6,9,16,17). 
Table 4 The aetiology of secondary acute severe community-acquired pneumonia in 86 patients 
Total number % of Blood and 
Micro-organisms of isolates positive cultures sputum Blood Sputum Serology 
Streptococcus pneumoniae 15 36.6 3 5 7 
Klebsiella pneumoniae* 12 29.3 5 6 
Other Gram negative 5 12.2 2 3 
Staphylococcus aweus 4 9.8 2 2 
Mixed Gram negative 4 9.8 4 
Viruses? 1 2.4 1 
*, Site of isolation in one case not documented. 
t, Escherichia coli (three cases), Haemophilus influenzae (l), Pseudomonas aeruginosa (1). 
$, Influenza virus infection documented on serology. 
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The reasons for the differences in aetiology noted 
in the various studies is uncertain. One possibility is 
that some studies showing many Gram-negative 
organisms have included patients with underlying 
disorders, known to be associated with increased 
colonization and/or invasive disease with Gram- 
negative organisms (513). The present study 
included a group of patients with so-called primary 
infections, specifically excluding cases with any 
such underlying disorders, and still found this high 
prevalence of K. pneumoniae infections. 
Another possibility suggested is that the high 
prevalence of Gram-negative infections may be 
associated with greater alcohol consumption by the 
patients (17). In the present study, we attempted to 
address this possibility, and although acknowledging 
that the data are based on a retrospective analysis of 
records, we were unable to show a significant differ- 
ence in alcohol consumption in the patients with 
pneumococcal and K. pneumoniae infections. 
A third possibility suggested by one author was 
that the method of diagnosis may make a difference, 
and that the use of more invasive techniques for the 
diagnosis of pneumonia may be associated with the 
documentation of more Gram-negative infections, 
even among non-critically ill patients (18). In the 
present study invasive techniques were not routinely 
used for diagnosis, yet the prevalence of Gram- 
negative infections was high. However, of these 
Gram-negative infections, 76% of the isolates in 
primary infections and 455% of the isolates of sec- 
ondary infections (69.4% for the group as a whole) 
were from blood culture, one of the gold standards of 
microbiological diagnosis. 
Thus, the exact reason(s) for our high prevalence 
of infection with K. pneumoniae still need to be 
elucidated. Our study population does differ some- 
what from patients from some of the other studies, 
in that the overwhelming majority of our cases 
are male, almost two-thirds have no underlying 
disorders, and in those cases with underlying 
illnesses, cardiovascular disease is not common. 
Nevertheless, we would suggest that many of these 
features should possibly be associated with a lower 
prevalence of Gram-negative infection, rather than 
be contributory. 
This high prevalence of K. pneumoniae infection 
has persisted in our ICU over several years, and is 
not a reflection of an outbreak of infection at any one 
particular time. The current study merely comple- 
ments our previous publication in 1989, documenting 
the high prevalence of K. pneumoniae infection 
during the initial 42 months since the establishment 
of our ICU (5). 
Although certain clinical features of illness are said 
to be characteristic of infection with K. pneumoniae, 
it is recognized that these features are not consistent 
enough to be of diagnostic value, and the clinical 
picture is often indistinguishable from that with 
pneumococcal infection (24). In an attempt to docu- 
ment clinical and laboratory features which would 
specifically alert one to the possibility of an ICU case 
being infected with a Gram-negative organism, we 
recently compared clinical, radiological and labora- 
tory features between patients with severe pneumo- 
coccal and K. pneumoniae infections, and found that 
a lower white cell and particularly a lower platelet 
count are more commonly found in the latter group 
of infections (19). 
Having identified the possibility of a patient being 
infected with a Gram-negative organism, raises the 
question as to the most appropriate therapy to insti- 
tute while awaiting the microbiological results. In a 
further study we conducted among patients with 
K. pneumoniae bacteraemia at our hospital, we 
clearly demonstrated that empiric therapy with the 
combination of a /i’-lactam and an aminoglycoside 
antibiotic to which the organism was susceptible was 
associated with a significantly better prognosis than 
any other form of therapy (25). The importance of 
aminoglycosides in the therapy of Gram-negative 
infections has been noted previously, and one study 
using multivariate analysis of factors associated 
with outcome demonstrated adequate peak con- 
centrations of these agents to be of paramount 
importance (26). 
Our suggested empiric choice of antibiotics for 
critically-ill patients with pneumonia, particularly in 
cases with a low white cell and platelet count, would 
therefore include a cephalosporin and an amino- 
glycoside. To this we would add erythromycin 
which would cover atypical infections such as with 
Legionella and Mycoplasma sp. which are a varying 
(and sometimes important) cause of infection even in 
the ICU (815-17). The choice of cephalosporin 
would depend on local susceptibility patterns of 
Gram-negative organisms. S. aureus is also a promi- 
nent cause of SCAP and should this organism be 
strongly suspected, based on the clinical features, 
more specific therapy should be added. In our experi- 
ence, with a low incidence of methicillin resistant 
S. aureus, we would usually consider cloxacillin. 
In conclusion, we recommend that empiric anti- 
biotic therapy for SCAP should include a second or 
third generation cephalosporin, erythromycin, and 
an aminoglycoside. The former two are recom- 
mended by both the British Thoracic Society (17) 
and the American Thoracic Society (27) and 
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experience in South Africa and elsewhere, makes a 15. 
good case for the addition of the latter (25-28). 
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